Plethora Solutions Holdings Plc

Plethora Solutions is a speciality pharmaceutical company dedicated to the development and marketing of products for the treatment and management of urological disorders. The company’s principal product is referred to under its development name of PSD 502, a treatment remedy for male premature ejaculation. The diagnosis and treatment of urological conditions represents an expanding market with many poorly met medical needs that offer significant commercial potential for new pharmaceutical products and medical devices.